missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. MINPP1 Rabbit anti-Human, Mouse, Rat, Polyclonal, Novus Biologicals™
  7. 18312034

MINPP1 Rabbit anti-Human, Mouse, Rat, Polyclonal, Novus Biologicals™

Rabbit Polyclonal Antibody

Brand:  Bio-Techne NBP3-04933-100UL

 View more versions of this product

Product Code. 18312034

  • 468.00€ / 100µL
Estimated Shipment: 30-01-2025
to see stock.
Explore more special offers
Add to basket
This item is not returnable. View return policy

Description

Description

MINPP1 Polyclonal specifically detects MINPP1 in Human, Mouse, Rat samples. It is validated for Western Blot.
Specifications

Specifications

MINPP1
Polyclonal
PBS with 50% glycerol, pH7.3.
Rabbit
Affinity purified
RUO
9562
Store at -20°C. Avoid freeze-thaw cycles.
IgG
Western Blot
Unconjugated
EC 3.1.3.62, HIPER1, Inositol (13,4,5)-tetrakisphosphate 3-phosphatase, Ins(13,4,5)P(4) 3-phosphatase, MINPP2, MIPPDKFZp564L2016, multiple inositol polyphosphate histidine phosphatase, 1, multiple inositol polyphosphate phosphatase 1, multiple inositol polyphosphate phosphatase 2, multiple inositol-polyphosphate phosphatase 1
Recombinant fusion protein containing a sequence corresponding to amino acids 298-487 of human MINPP1 (NP_004888.2).
100 μL
Primary
Human, Mouse, Rat
Purified
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Special Offers

Special Offers

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.